Top line decelerating.
+6.4% YoY versus +9.9% prior. 3y CAGR +9.1%.
+6.4%We use cookies
MainRatios uses cookies for essential site functions. With your consent, we also use analytics cookies including session replay sampling (PostHog, Google Analytics) and advertising cookies (Google AdSense). You can reject non-essential cookies, including the "sale" or sharing of personal information under CCPA, and you may withdraw consent at any time (GDPR). See our Privacy Policy for details.
Financial Services · Market Cap: $97.7B
Live price unavailable
Fundamentals as of 2026-03-31
All analysis on this page is for educational purposes only and does not constitute financial advice. Fair values are model-based estimates. Always do your own research.
The Question
Mixed — CME Group Inc. has 15.9% ROE but D/E 6.59.
Financial story
Mixed — CME Group Inc.'s 15.9% ROE is strong, but its 6.59 debt-to-equity is elevated.
Bottom line: CME currently has no legendary investor models qualifying — see /stock/CME/valuation for the per-model breakdown, but earns a B sector grade (62/100) in Financial Services. Use the per-tab analysis to form your own view. Drill into the valuation breakdown and sector ranking for the full picture.
How does CME compare?
0 of 6 legendary investor models rate CME a BUY. Fair value estimates and full investor breakdown are in the valuation tab.
CME Group Inc.'s fair value depends on which model you trust. See the per-investor fair-value table in the valuation tab.
CME trades at 24.3x earnings. Sector context and per-investor signals are in the valuation tab.
CME and ICE differ on P/E, ROE, and revenue growth. See the full CME vs ICE compare matrix.
Investor verdicts for CME are listed in the valuation tab. Per-model fair value and reasoning are in the valuation tab.
CME's P/E ratio is 24.3x. 5-year P/E history is in the financials tab.
See exactly where CME ranks
Sign in to unlock the full sector ranking — free.
Sign in to see the rankingCME sits at #8 in Financial Services with a B grade (62/100).